Apollo Hospitals Enterprise Limited announced its financial results for the first quarter of Fiscal Year 2027 (Q1 FY27). The company reported a consolidated revenue of ₹70,435 million, marking a 21% increase year-over-year. EBITDA grew by 28% to ₹10,920 million, and Profit After Tax (PAT) saw a substantial 34% rise to ₹5,805 million, reflecting strong operational performance across its healthcare services and digital platforms.
Apollo Hospitals Reports Strong Q1 FY27 Performance
Apollo Hospitals Enterprise Limited has disclosed its financial results for the quarter ended June 30, 2026 (Q1 FY27), showcasing significant growth across key financial metrics. The company’s consolidated revenue reached ₹70,435 million, an increase of 21% compared to the same period in the previous fiscal year. This growth underscores the sustained demand and expansion of its diverse healthcare offerings.
Key Financial Highlights
The company’s Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) demonstrated robust growth, rising by 28% to ₹10,920 million. The EBITDA margin stood at 15.5%. Furthermore, the Profit After Tax (PAT) recorded a substantial year-over-year increase of 34%, reaching ₹5,805 million, indicating improved profitability and operational efficiency.
Segmental Performance Overview
The financial report also provided insights into the performance of its business segments:
- Healthcare Services revenue grew by 22%.
- Apollo HealthCo revenue increased by 20%.
- AHLL (Diagnostics & Retail Health) revenue saw a growth of 15%.
This diversified growth highlights the company’s strategic focus and successful execution across its primary healthcare verticals.
Expansion and Initiatives
The presentation also detailed ongoing initiatives and expansions. In the Healthcare Services segment, the company noted the commissioning of 5 new hospitals in the last two quarters and highlighted operational updates for established units. For AHLL, it emphasized the net addition of collection centers and growth in its wellness and specialty segments. Apollo HealthCo showcased advancements in its digital platform, Apollo 24/7, and its pharmacy distribution network, along with initiatives in telehealth and digital healthcare services.
The company also provided an update on the proposed composite scheme for Apollo HealthCo, aiming to create a more integrated omni-channel healthcare platform.
Source: BSE
